HomeSVA • TSE
add
Sernova Biotherapeutics Inc
Previous close
$0.13
Day range
$0.13 - $0.14
Year range
$0.12 - $0.26
Market cap
43.06M CAD
Avg Volume
119.62K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.40M | -48.84% |
Net income | -2.20M | 55.77% |
Net profit margin | — | — |
Earnings per share | -0.01 | 43.88% |
EBITDA | -2.34M | 49.61% |
Effective tax rate | 2.44% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 265.00K | -95.59% |
Total assets | 764.23K | -89.85% |
Total liabilities | 25.84M | 26.15% |
Total equity | -25.08M | — |
Shares outstanding | 336.70M | — |
Price to book | -1.62 | — |
Return on assets | -715.31% | — |
Return on capital | 29.92% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | -2.20M | 55.77% |
Cash from operations | -171.13K | 95.64% |
Cash from investing | 20.17K | — |
Cash from financing | 332.34K | -93.24% |
Net change in cash | 181.39K | -81.73% |
Free cash flow | 15.84K | 100.78% |
About
Founded
2006
Headquarters
Website
Employees
8
